Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis

dc.contributor.authorHuvila Jutta
dc.contributor.authorPors Jennifer
dc.contributor.authorThompson Emily F
dc.contributor.authorGilks C Blake
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.converis.publication-id51873825
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/51873825
dc.date.accessioned2022-10-27T11:52:49Z
dc.date.available2022-10-27T11:52:49Z
dc.description.abstract<p>Endometrial carcinoma (EC) is classified into a wide range of morphological variants; this list has expanded over the past decade with the inclusion of mesonephric-like and de-differentiated carcinoma as EC variants in the fifth edition of the WHO Classification of Female Genital Tumours, and recognition that carcinosarcoma is a biphasic carcinoma rather than a sarcoma. Each EC variant has distinct molecular abnormalities, including TCGA-based molecular subtypes, allowing further subclassification and adding complexity. In contrast to this rapid progress in understanding EC, there are only two recognized EC precursor lesions: endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia (EAH/EIN) and serous intraepithelial carcinoma, a situation that has not changed for many years. Diagnosis of EC precursors is a cornerstone of surgical pathology practice, with early diagnosis contributing to the relatively favorable prognosis of EC. In this review we relate the precursor lesions to each of the EC morphological variants and molecular subtypes, discuss how successful early diagnosis is for each variant/molecular subtype and how it might be improved, and identify knowledge gaps where there is insufficient understanding of EC histogenesis.</p>
dc.identifier.eissn1096-9896
dc.identifier.jour-issn0022-3417
dc.identifier.olddbid172509
dc.identifier.oldhandle10024/155603
dc.identifier.urihttps://www.utupub.fi/handle/11111/30246
dc.identifier.urnURN:NBN:fi-fe2021042821690
dc.language.isoen
dc.okm.affiliatedauthorHuvila, Jutta
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3122 Cancersen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.discipline3122 Syöpätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA2 Scientific Article
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.doi10.1002/path.5608
dc.relation.ispartofjournalJournal of Pathology
dc.relation.issue4
dc.relation.volume253
dc.source.identifierhttps://www.utupub.fi/handle/10024/155603
dc.titleEndometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis
dc.year.issued2021

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
path.5608.pdf
Size:
3.75 MB
Format:
Adobe Portable Document Format
Description:
Final draft